A common HIV drug has been shown to improve the connections between memories in aging mice. The findings could help reveal how contextual events are remembered in the human brain, and why this becomes harder as we age.
VANCOUVER, Washington, March 05, 2021 CytoDyn Inc. , a late-stage biotechnology company developing Vyrologix™ , a CCR5 antagonist with the potential for multiple therapeutic. | March 11, 2021